Search clinical trials for: Vehicle Gel Base

Total 12617 results

AOBiome LLC
Veristat, Inc.

Completed

A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

Prehypertension | Hypertension, Stage I

United States
Vyne Therapeutics Inc.

Completed

Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Australia
AiViva BioPharma, Inc.

Withdrawn

A Safety and Efficacy Study to Evaluate Rosacea

Papulopustular Rosacea

United States
Dermira, Inc.

Completed

A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis

Atopic Dermatitis

Canada
Dermira, Inc.

Completed

A Safety and Efficacy Study of DRM02 in Subjects With Rosacea

Rosacea

Canada
Novartis Pharmaceuticals

Withdrawn

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Basal Cell Carcinoma

Greece, Switzerland, Germany, United Kingdom, Belgium, Canada, Czechia, Finland, Italy, Spain
Maruho North America Inc.

Completed

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

Psoriasis

United States
Allergan

Completed

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Dry Eye Syndromes

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
AOBiome LLC
Veristat, Inc.

Completed

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States
Dermira, Inc.

Completed

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

Psoriasis

Canada
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Inflammation | Cataract | Surgery

United States
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

Keratitis | Corneal Ulcer

France
Maruho Co., Ltd.

Completed

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Maruho North America Inc.

Completed

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Psoriasis

United States
Taisho Pharmaceutical R&D Inc.

Completed

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

Atopic Dermatitis

United States
International Partnership for Microbicides, Inc.

Completed

A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

HIV-1 Infections

United States
Universidad de Murcia

Unknown

Clinical Study New Gel for Xerostomia (XEROSTOMIA)

XEROSTOMIA

Spain
Galderma R&D

Withdrawn

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema

Erythema
NHS Lothian
University of Edinburgh

Withdrawn

A Trial of Topical Aloe Vera Gel in Emergency Department Patients Presenting With Simple Traumatic Wounds (ALOE)

Injuries and Wounds

United Kingdom
Glia, LLC
ORA, Inc.

Completed

Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

Chronic Ocular Graft-versus-host Disease

United States
Izun Pharma Ltd

Completed

Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

Israel
Galderma R&D

Completed

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea

Rosacea

Russian Federation, France, Sweden
University of South Carolina
Centers for Disease Control and Prevention

Active, not recruiting

Phone-Based Based Walk With Ease Program for Adults With Arthritis

Arthritis | Osteoarthritis | Rheumatoid Arthritis | Lupus Erythematosus, Systemic | Fibromyalgia | Gout

United States
Population Council

Completed

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

HIV

United States
LEO Pharma

Terminated

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Discoid Lupus Erythematosus

United States, France, Germany, Denmark
LEO Pharma

Completed

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

Chronic Hand Eczema

United States, Germany, Denmark
LEO Pharma

Completed

Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream

Healthy Volunteers

Germany
Pfizer

Completed

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Dermatitis, Atopic

Australia
Gage Development Company, LLC

Completed

Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses

Actinic Keratosis

United States
Memorial University of Newfoundland

Recruiting

Biofreeze and the Effect on Knee Osteoarthritis

Knee Osteoarthritis

Canada
October 6 University

Completed

Effect of Ozone Gel on Treatment of Chronic Periodontitis

Periodontal Diseases

Egypt
Tarsus Pharmaceuticals, Inc.

Active, not recruiting

Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex (Rhea)

Meibomian Gland Dysfunction | Blepharitis | Demodex Infestation of Eyelid | Demodectic Blepharitis

United States
LEO Pharma

Completed

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Atopic Dermatitis

United States, Canada, Australia
SIFI SpA

Completed

Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome (ProGIFT)

Dry Eye Disease

Italy
Government Dental College and Research Institute...

Completed

Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis

Chronic Periodontitis

India
Galderma R&D

Completed

Dose Range Study of CD5789 in Acne Vulgaris

Acne Vulgaris

United States
Assiut University

Recruiting

Oropharyngeal Leak Pressure Monitoring Using Baska Versus I-gel Laryngeal Mask Airway

Laryngeal Masks

Egypt
PharmaDax Inc.
Glia, LLC

Enrolling by invitation

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

Keratoconjunctivitis Sicca | Dry Eye Syndrome

Taiwan
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Palvella Therapeutics, Inc.

Recruiting

A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita (VAPAUS)

Pachyonychia Congenita

United States, United Kingdom
Cairo University

Recruiting

Effect of Nano-Bio Fusion Gel on Palatal Wound Healing After Free Gingival Graft Harvest.

Free Gingival Graft

Egypt
Topokine Therapeutics, Inc.

Completed

Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers

Lipodystrophy | Lipoatrophy | Nasolabial Folds

United States
OnQuality Pharmaceuticals (USA) LLC

Active, not recruiting

A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients (NOVA-II)

Hand-Foot Skin Reaction (HFSR)

United States, China, India
Orasis Pharmaceuticals Ltd.

Completed

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Presbyopia

United States
Maruho Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Rosacea

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Netherlands, Sweden
Pfizer

Completed

A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Atopic Dermatitis

China, United States, Turkey, Australia, Canada, Israel
Northwestern University

Terminated

Collagen Injections for the Treatment of Acne Scars and Wrinkles

Acne Scars | Wrinkles

United States
Qurient Co., Ltd.

Completed

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Atopic Dermatitis

United States

3

Subscribe